UNH - Option Care Health: Top Infusion Therapy Player With Promising Growth Prospects

• Option Care Health is expanding its position in chronic illness infusion therapy, increasing its physician networks, and strengthening relationships with insurance companies.
• The total addressable market for infusion therapy is approximately $100 billion, with approximately 14% currently addressed.
• Option Care Health has been around for over 40 years and it outcompetes CVS Health, UnitedHealth Group, and over 800 smaller players in the infusion therapy medical care niche.
• OPCH leverages an integrated technology ecosystem comprising names such as Oracle, AlayaCare, WellSky, Salesforce, and Workday to enhance the patient experience at a low cost.
• Based on DCF valuation, the OPCH stock offers an attractive risk to reward ratio with a $3 downside and $48 upside for long-term investors.

For further details see: